Since the auxiliary partial orthotopic liver transplantation (APOLT) was successfully applied as a clinical treatment for the acute liver failure in 1989, the indication of APOLT has been gradually expanded to the liver failure, the metabolic liver disease and the endstage liver cirrhosis. With the surgical technique gradually coming to a mature stage, the postoperative complication rate is significantly reduced and the long-term survival outcome sees an encouraging up-trend. In selected patients such as those of acute liver failure, APOLT even offers an advantage over the orthotopic liver transplantation, which was regard as the standard for these diseases. The emergence of new types of APOLT such as the Domino APOLT and the Cross-Domino APOLT will significantly expand the donor source and the beneficiaries. The APOLT has become an important treatment of liver diseases.

liver transplantation  /  auxiliary partial orthotopic liver transplantation  /  acute liver failure  /  metabolic liver disease